Anxiety and sleep disorders
https://doi.org/10.21518/2079-701X-2022-16-11-108-113
Abstract
Anxiety disorders are widespread among patients of primary care physicians and are the cause of increased morbidity and access to healthcare. Anxiety is a reaction of the body to the effects of stress and is manifested by the development of psychovegetative syndrome. In the general population, 5 to 7% of people have clinically significant anxiety, and in the practice of primary care physicians, these disorders are detected in every fourth patient. Anxiety disorder contributes to the development of psychogenic somatic pathology and/or negatively affects the course of background disease. Most patients with anxiety disorders suffer from various sleep disorders. In general practice, the frequency of sleep disorders reaches 73%. Chronic sleep disorder can act as a stressor that contributes to the development of pathophysiological changes in the body and increases anxiety. The above determines the need for early detection of sleep disorders and its timely treatment. The current treatment strategy for patients with sleep disorders involves an individualized approach to insomnia therapy. The existing arsenal of drugs used to treat sleep disorders allows this principle to be applied taking into account concomitant diseases (including anxiety disorders). The choice of product is also determined by good tolerability, efficacy and high safety profile. The optimal drug that answers the above requirements is doxylamine succinate, which allows you to effectively stop both anxiety symptoms and sleep disorders. Due to its high safety profile, doxylamine succinate can be used in the treatment of insomnia in pregnant women. The release form determines the convenience of use and the possibility of selecting an individual dose of the drug.
About the Authors
E. Yu. Ebzeeva
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Elizaveta Yu. Ebzeeva, Cand. Sci. (Med.), Associate Professor, Associate Professor of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
O. A. Polyakova
Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
Olga A. Polyakova, Therapist, Assistant of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
References
1. Vorobeva O.V. Stress-induced psychovegetative reactions. RMJ. 2005;13(12):798–801. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Stressinducirovannye_psihovegetativnye_reakcii/.
2. Selye H. The story of the adaptation syndrome. Canada: Medical Publishers; 1952. 225 p. Available at: https://djvu.online/file/F5CyMpbH98nY1.
3. Kotova O.V., Akarachkova E.S., Belyaev A.A. Psychovegetative syndrome: diagnosis and diagnosis of treatment. Meditsinskiy Sovet. 2018;18(21):50–55. (In Russ.) https://doi.org/10.21518/2079-701X-2018-21-50-55.
4. Cox R.C., Olatunji B.O. A systematic review of sleep disturbance in anxiety and related disorders. J Anxiety Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001.
5. Stein M.B., Enns M.W., Kryger M.H. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J Affect Disord. 1993;28(1):1–6. https://doi.org/10.1016/0165-0327(93)90071-q.
6. Alfano C.A., Patriquin M.A., De Los Reyes A. Subjective – objective sleep comparisons and discrepancies among clinically-anxious and healthy children. J Abnorm Child Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802-015-0018-7.
7. Poluektov M., Preobrazhenskaya I. Sleep and cognitive dysfunctions. Therapeutic approach. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(1):68–73. (In Russ.) https://doi.org/10.14412/2074-2711-2014-1-68-73.
8. Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213.
9. Esin R.G., Esin O.R., Khakimova A.R. Stress-induced disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(5):131–137. (In Russ.) https://doi.org/10.17116/jnevro2020120051131.
10. Wittchen H.-U. Generalized anxiety disorder: prevalence, burden and cost to society. Depression Anxiety. 2002;16(4):162–172. https://doi.org/10.1002/da.10065.
11. Noyes R.J., Hoehn-Saric R. The anxiety disorders. UK: Cambridge University Press; 1998. 343 p. https://doi.org/10.1017/CBO9780511663222.
12. Logue M.B., Thomas A.M., Barbee J.G., Hoehn-Saric R., Maddock R.J., Schwab J. et al. Generalized anxiety disorder patients seek evaluation for cardiological symptoms at the same frequency as patients with panic disorder. J Psychiatr Res. 1993;27(1):55–59. https://doi.org/10.1016/0022-3956(93)90049-8.
13. Shavlovskaya О.A. Anxiety therapy. Meditsinskiy Sovet. 2019;(6):42–46. (In Russ.) https://doi.org/10.21518/2079-701X-2019-6-42-46.
14. Kovalzon V.M. Fundamentals of somnology. Physiology and neurochemistry of the wake-sleep cycle. Moscow: Binom; 2012. 239 p. (In Russ.) Available at: https://sleep.ru/download/Osnovue_somnologii.
15. Veyn A.M., Voznesenskaya T.G., Vorobeva T.V. Vegetative disorders: Clinic, diagnosis, treatment. Moscow: MIA; 2010. 640 p. (In Russ.)
16. Thorpy M.J. Classification of sleep disorders. Neurotherapeutics. 2012;9(4):687–701. https://doi.org/10.1007/s13311-012-0145-6.
17. Gordeev K.S., Ermolaeva E.L., Zhidkov A.A., Ilyushina E.S., Fedoseeva L.A. Physiology of sleep and its impact on the work of the human brain. Modern Scientific Research and Innovation. 2018;(12). (In Russ.) Available at: https://web.snauka.ru/issues/2018/12/88012.
18. Levin Y.I. Sleep, insomnia, doxylamine (Donormil). RMJ. 2007;(10):850. (In Russ.) https://www.rmj.ru/articles/nevrologiya/Son_insomniya_doksilamin_Donormil/?
19. Hsieh K.C., Nguyen D., Siegel J.M., Lai Y.Y. New pathways and data on rapid eye movement sleep behaviour disorder in a rat model. Sleep Med. 2013;14(8):719–728. https://doi.org/10.1016/j.sleep.2012.08.008.
20. Diekelmann S. Sleep for cognitive enhancement. Front Syst Neurosci. 2014;8:46. https://doi.org/10.3389/fnsys.2014.00046.
21. Torgashov M.N., Myakotnykh V.S. Some pathogenetic mechanisms of development of stress-induced pathology. Vestnik Uralskoi Meditsinskoi Akademicheskoi Nauki. 2016;(2):64–74. (In Russ.) https://doi.org/10.22138/2500-0918-2016-14-2-64-74.
22. Fava G.A., Cosci F., Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86(1):13–30. https://doi.org/10.1159/000448856.
23. McEwen B.S., Karatsoreos I.N. Sleep deprivation and circadian disruption: Stress, allostasis, and allostatic load. Sleep Med Clin. 2015;10(1):1–10. https://doi.org/10.1016/j.jsmc.2014.11.007.
24. Pshennikova M.G. Stress: regulatory systems and resistance to stress damage. In: Kryzhanovskiy G.N. (ed.) Dysregulation pathology. Moscow: Medicine; 2002, pp. 307–328. (In Russ.)
25. Oh C.-M., Kim H.Y., Na H.K., Cho K.H., Chu M.K. The Effect of anxiety and depression on sleep quality of individuals with high risk for insomnia: A population-based study. Front Neurol. 2019;10:849. https://doi.org/10.3389/fneur.2019.00849.
26. Omisade A., Buxton O.M., Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav. 2010;99(5):651–656. https://doi.org/10.1016/j.physbeh.2010.01.028.
27. Abercrombie H.C., Kalin N.H., Davidson R.J. Acute cortisol elevations cause heightened arousal ratings of objectively nonarousing stimuli. Emotion. 2005;5(3):354–359. https://doi.org/10.1037/1528-3542.5.3.354.
28. Goldstein A.N., Walker M.P. The role of sleep in emotional brain function. Annu Rev Clin Psychol. 2014;10:679–708. https://doi.org/10.1146/annurevclinpsy-032813-153716.
29. Nilsson J.P., Söderström M., Karlsson A.U., Lekander M., Akerstedt T., Lindroth N.E., Axelsson J. Less effective executive functioning after one night’s sleep deprivation. J Sleep Res. 2005;14(1):1–6. https://doi.org/10.1111/j.1365-2869.2005.00442.x.
30. Goel N., Rao H., Durmer J.S., Dinges D.F. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2009;29(4):320–339. https://doi.org/10.1055/s-0029-1237117.
31. Pickett S.M., Barbaro N., Mello D. The relationship between subjective sleep disturbance, sleep quality, and emotion regulation difficulties in a sample of college students reporting trauma exposure. Psychol Trauma. 2016;8(1):25–33. https://doi.org/10.1037/tra0000064.
32. Ivarsson T., Skarphedinsson G. Sleep problems and cognitive behavior therapy in pediatric obsessive-compulsive disorder have bidirectional effects. J Anxiety Disord. 2015;30:28–33. https://doi.org/10.1016/j.janxdis.2014.12.009.
33. Vasilyeva A.V. Using the Neuroscanner mobile application in the diagnosis of anxiety disorders and the choice of therapy. Lechaschi Vrach. 2020. (In Russ.) Available at: https://www.lvrach.ru/partners/grandaxin/15437807.
34. Vasilyeva A.V. Actual problems of diagnosis of depressive disorders. Lechaschi Vrach. 2020. (In Russ.) Available at: https://www.lvrach.ru/partners/velaxin/15437705.
35. Ivanova L.A. Anxiety disorders therapy in general practice. Acta Biomedica Scientifica. 2017;2(5):121–124. (In Russ.) https://doi.org/10.12737/article_5a3a0e7b6a3885.64967546.
36. Kutashov V.A. A modern approach to the treatment of autonomic disorders in patients under stressful conditions. Meditsinskiy Sovet. 2018;(18):92–95. (In Russ.) https://doi.org/10.21518/2079-701X-2018-18-92-95.
37. Burchakov D.I., Zabaluyev K.A., Chilova R.A. Doxylamine: efficiency, safety and the place in the clinical practice. Effective Pharmacotherapy. 2019;15(44):48–52. (In Russ.) Available at: https://umedp.ru/upload/iblock/df2/Burchakov.pdf.
38. Babak S.L., Golubev L.A., Gorbunova M.V. Chronic insomnia in the clinical practice of a therapist. RMJ. 2008;16(5):259–266. (In Russ.) Available at: https://www.rmj.ru/articles/nevrologiya/Hronicheskaya_insomniya_i_obstruktivnoe__apnoe_sna_sovremennaya_dilemma__v_klinicheskoy_praktike_terapevta/?
Review
For citations:
Ebzeeva EY, Polyakova OA. Anxiety and sleep disorders. Meditsinskiy sovet = Medical Council. 2022;(11):108-113. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-11-108-113
Views:
658
Email this article 